Nanox Integrates AI for Enhanced Second Opinion CT Scan Reviews – ExecEdge
Now Reading:
Nanox Integrates AI for Enhanced Second Opinion CT Scan Reviews
Full Article 40 second read

Nanox Integrates AI for Enhanced Second Opinion CT Scan Reviews

By Daniella Parra

NANO-X IMAGING LTD (Nasdaq: NNOX) has integrated FDA-cleared AI solutions into its Second Opinions online consultation service, offered by its subsidiary, USARAD Holdings INC, the company said.

This platform connects patients with specialists for additional diagnostic consultations, it said.

The AI tools for early detection of chronic conditions through CT scans include detection of early signs of coronary artery disease, bone mineral density to highlight osteoporosis risks, and liver density to indicate fatty liver disease, the company said.

“We will continue exploring opportunities to leverage our AI technology to promote accessible early diagnosis and preventative management,” Erez Meltzer, Nanox Chief Executive Officer, said.

Contact:

Executives-Edge.com

Editor@executives-edge.com

Leave a Reply

Your email address will not be published. Required fields are marked *

Input your search keywords and press Enter.